FULC Earnings

Quarterly EPS
$-0.35
Q3 2024
$-0.27
Q4 2024
$-0.28
Q1 2025
$-0.28
Q2 2025
$-0.31
Q3 2025
$-0.31
Q4 2025
$-0.25
Q1 2026
$-0.34
Q2 2026
Latest RevenueN/A
Latest Net Income-26179000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.34-26179000-21.4%
Q1 2026-$0.25-18891000+10.7%
Q4 2025-$0.31-20334000-14.8%
Q3 2025-$0.31-19595000+11.4%
Q2 2025-$0.28-17296000-131.5%
Q1 2025-$0.28-17655000+34.9%
Q4 2024-$0.270-16568000-100.0%+32.5%
Q3 2024-$0.35-21696000+10.3%
Q2 2024$0.8980.0M55.4M
Q1 2024-$0.43-26870000
Q4 2023-$0.40871.0K-24756000
Q3 2023-$0.39759.0K-24017000
Fulcrum Therapeutics (FULC) — Earnings